These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 26315872

  • 1. 124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma.
    Cistaro A, Quartuccio N, Caobelli F, Piccardo A, Paratore R, Coppolino P, Sperandeo A, Arnone G, Ficola U.
    Nucl Med Rev Cent East Eur; 2015; 18(2):102-6. PubMed ID: 26315872
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
    Dhull VS, Sharma P, Patel C, Kundu P, Agarwala S, Bakhshi S, Bhatnagar V, Bal C, Kumar R.
    Nucl Med Commun; 2015 Oct; 36(10):1007-13. PubMed ID: 26049371
    [Abstract] [Full Text] [Related]

  • 3. PET/CT imaging in neuroblastoma.
    Piccardo A, Lopci E, Conte M, Foppiani L, Garaventa A, Cabria M, Villavecchia G, Fanti S, Cistaro A.
    Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):29-39. PubMed ID: 23474633
    [Abstract] [Full Text] [Related]

  • 4. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
    Papathanasiou ND, Gaze MN, Sullivan K, Aldridge M, Waddington W, Almuhaideb A, Bomanji JB.
    J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
    [Abstract] [Full Text] [Related]

  • 5. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
    Kroiss A, Putzer D, Uprimny C, Decristoforo C, Gabriel M, Santner W, Kranewitter C, Warwitz B, Waitz D, Kendler D, Virgolini IJ.
    Eur J Nucl Med Mol Imaging; 2011 May; 38(5):865-73. PubMed ID: 21279352
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.
    Piccardo A, Lopci E, Conte M, Garaventa A, Foppiani L, Altrinetti V, Nanni C, Bianchi P, Cistaro A, Sorrentino S, Cabria M, Pession A, Puntoni M, Villavecchia G, Fanti S.
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):57-71. PubMed ID: 21932116
    [Abstract] [Full Text] [Related]

  • 7. The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy.
    Piccardo A, Treglia G, Fiz F, Bar-Sever Z, Bottoni G, Biassoni L, Borgwardt L, de Keizer B, Jehanno N, Lopci E, Kurch L, Massollo M, Nadel H, Roca Bielsa I, Shulkin B, Vali R, De Palma D, Cecchin D, Santos AI, Zucchetta P.
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):756-767. PubMed ID: 37962616
    [Abstract] [Full Text] [Related]

  • 8. Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.
    Xia J, Zhang H, Hu Q, Liu SY, Zhang LQ, Zhang A, Zhang XL, Wang YQ, Liu AG.
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):649-660. PubMed ID: 29058276
    [Abstract] [Full Text] [Related]

  • 9. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
    Seo Y, Gustafson WC, Dannoon SF, Nekritz EA, Lee CL, Murphy ST, VanBrocklin HF, Hernandez-Pampaloni M, Haas-Kogan DA, Weiss WA, Matthay KK.
    Mol Imaging Biol; 2012 Dec; 14(6):735-42. PubMed ID: 22382618
    [Abstract] [Full Text] [Related]

  • 10. [18F]MFBG PET/CT outperforming [123I]MIBG SPECT/CT in the evaluation of neuroblastoma.
    Wang P, Li T, Liu Z, Jin M, Su Y, Zhang J, Jing H, Zhuang H, Li F.
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3097-3106. PubMed ID: 37160439
    [Abstract] [Full Text] [Related]

  • 11. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
    Rufini V, Treglia G, Castaldi P, Perotti G, Calcagni ML, Corsello SM, Galli G, Fanti S, Giordano A.
    Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
    [Abstract] [Full Text] [Related]

  • 12. Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.
    Lee CL, Wahnishe H, Sayre GA, Cho HM, Kim HJ, Hernandez-Pampaloni M, Hawkins RA, Dannoon SF, VanBrocklin HF, Itsara M, Weiss WA, Yang X, Haas-Kogan DA, Matthay KK, Seo Y.
    Med Phys; 2010 Sep; 37(9):4861-7. PubMed ID: 20964203
    [Abstract] [Full Text] [Related]

  • 13. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
    Kushner BH, Yeung HW, Larson SM, Kramer K, Cheung NK.
    J Clin Oncol; 2001 Jul 15; 19(14):3397-405. PubMed ID: 11454888
    [Abstract] [Full Text] [Related]

  • 14. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
    Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL.
    J Nucl Med; 2009 Aug 15; 50(8):1237-43. PubMed ID: 19617326
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.
    Piccardo A, Puntoni M, Lopci E, Conte M, Foppiani L, Sorrentino S, Morana G, Naseri M, Cistaro A, Villavecchia G, Fanti S, Garaventa A.
    Eur J Nucl Med Mol Imaging; 2014 Jun 15; 41(6):1046-56. PubMed ID: 24562643
    [Abstract] [Full Text] [Related]

  • 16. Case report of PET/CT imaging of a patient with neuroblastoma using 18F-FPBG.
    Suh M, Park HJ, Choi HS, So Y, Lee BC, Lee WW.
    Pediatrics; 2014 Dec 15; 134(6):e1731-4. PubMed ID: 25422010
    [Abstract] [Full Text] [Related]

  • 17. 124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma.
    Aboian MS, Huang SY, Hernandez-Pampaloni M, Hawkins RA, VanBrocklin HF, Huh Y, Vo KT, Gustafson WC, Matthay KK, Seo Y.
    J Nucl Med; 2021 Jan 15; 62(1):43-47. PubMed ID: 32414950
    [Abstract] [Full Text] [Related]

  • 18. 68Ga-DOTATATE PET in Restaging and Response to Therapy in Neuroblastoma: A Case Series and a Mini Review.
    AlSadi R, Maaz AUR, Bouhali O, Djekidel M.
    J Nucl Med Technol; 2023 Jun 15; 51(2):140-146. PubMed ID: 37192823
    [Abstract] [Full Text] [Related]

  • 19. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP.
    J Clin Endocrinol Metab; 2009 Oct 15; 94(10):3922-30. PubMed ID: 19622618
    [Abstract] [Full Text] [Related]

  • 20. Added value of SPECT/CT for correlation of MIBG scintigraphy and diagnostic CT in neuroblastoma and pheochromocytoma.
    Rozovsky K, Koplewitz BZ, Krausz Y, Revel-Vilk S, Weintraub M, Chisin R, Klein M.
    AJR Am J Roentgenol; 2008 Apr 15; 190(4):1085-90. PubMed ID: 18356459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.